Galera Therapeutics is focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.

For more information, visit Galera Therapeutics or follow their updates on:

Galera Therapeutics Raises $150 Million to Advance “Breakthrough Therapy” for Debilitating Cancer Side Effect

Dollar sign fundraising

12 Fundraising Tips for BioTech Companies from Cultivation Capital’s Life Sciences Fund

BioGenerator

Cultivation Capital’s Life Sciences Fund Finds Sweet Spot

Veniti’s CFO Catherine Matthes on Clinical Trial Funding

Robert Beardsley on Galera Therapeutics’ High Growth